Kopp Family Office’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.18M | Sell |
|
|||||
|
2025
Q2 | $2.84M | Sell |
|
|||||
|
2025
Q1 | $2.77M | Hold |
|
|||||
|
2024
Q4 | $3.94M | Sell |
|
|||||
|
2024
Q3 | $4.68M | Hold |
|
|||||
|
2024
Q2 | $2.68M | Buy |
|
|||||
|
2024
Q1 | $3.6M | Buy |
|
|||||
|
2023
Q4 | $4.48M | Sell |
|
|||||
|
2023
Q3 | $3.29M | Hold |
|
|||||
|
2023
Q2 | $5.1M | Buy |
|
|||||
|
2023
Q1 | $3.34M | Buy |
|
|||||
|
2022
Q4 | $1.88M | Buy |
|